DALACIN T

This brand name is authorized in Estonia, Hong Kong SAR China, Ireland, Japan, Mexico, Netherlands, Poland, Singapore, South Africa, UK.

Active ingredients

The drug DALACIN T contains one active pharmaceutical ingredient (API):

1	Clindamycin UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
	Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
	Read more about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DALACIN T Topical solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AF01	Clindamycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1021914
GB	Medicines & Healthcare Products Regulatory Agency	142188, 180555, 180557, 182473, 195001, 26849
HK	Department of Health Drug Office	31425, 37045, 37199
IE	Health Products Regulatory Authority	19674
JP	医薬品医療機器総合機構	2634713M1020, 2634713Q1021
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	115M86, 439M93
NL	Z-Index G-Standaard	14040484
NL	Z-Index G-Standaard, PRK	19666
PL	Rejestru Produktów Leczniczych	100016950, 100016966, 100078861, 100286890, 100332199, 100340477, 100349550, 100352635, 100353149, 100426180, 100462384
SG	Health Sciences Authority	01338P, 07338P, 09700P
ZA	Health Products Regulatory Authority	P/20.1.6/63, Y/20.1.6/326